电针治疗30例急性缺血性脑卒中患者的脑电图临床观察

目的：本研究旨在对电针治疗急性缺血性脑卒中患者脑电图的频率、波幅进行观察分析,进而从神经电生理方面对其疗效进行评估。方法：90例急性缺血性脑卒中患者随机分为空白组,普通针刺组、电针组,每组30人,空白组对梗死侧进行10min脑电监测,针刺组在针刺得气后立即对梗死侧进行10min脑电监测,并记录脑电图监测结果,对梗死侧脑电图波幅、频率进行分析。结果：普通针刺组、电针组患者脑电频率较空白组增快,其中电针组差异有统计学意义（P〈0.05）,而普通针刺组差异无统计学意义（P〉0.05）;电针组比普通针刺组脑电频率增快,差异有统计学意义（P〈0.05）。普通针刺组、电针组患者脑电波幅较空白组增加,但差异无统计学意义（P〉0.05）;电针组脑电波幅较普通针刺组波幅增加,但两者差异无统计学意义（P〉0.05）。结论：电针治疗缺血性脑卒中患者脑电图波幅、频率不同程度增加、增快,其中频率的变化更有意义,进而从神经电生理方面证实了电针治疗急性缺血性脑卒中有效,脑电图可作为针灸治疗缺血性脑卒中的客观评价手段。

Analysis of EEG With Acupuncture Treatment of 30 Cases of Acute Ischemic Stroke

Objective：To assess the effect of acupuncture,by observing EEG changes of acute ischemic stroke patients.Methods：A total of 90 cases of acute ischemic stroke patients were randomly divided into control group,normal acupuncture group and Electricity Acupuncture group,30 coses in each group.Minitoring EEG on infarct side of every group for 10 min,and record the EEG monitoring results,analysis EEG amplitude,frequency on the infarct side of patients.Results：EEG frequency of Normal acupuncture group,EA group was faster than the control group,in which the EA group difference was statistically significant（P 0.05）,while the normal acupuncture group showed no significant difference（P 0.05） ;EEG frequency of electricity acupuncture group was faster than normal group,the difference was statistically significant（P 0.05）.Normal acupuncture group,electro-acupuncture group compared with the control group,the EEG amplitude increased,but the difference was not statistically significant（P 0.05） ;EEG amplitude of EA group was more obviously increased than normal acupuncture group,but the difference was not statistically significance（P 0.05）.Conclusion：EEG amplitude,frequency of ischemic stroke patients by Electro-acupuncture treatment are more increased and faster,which is more meaningful change in frequency,and confirmed EA treatment of acute ischemic stroke are effective from the neurophysiological aspects,thus EEG can be used as objective evaluation tool of acupuncture treatment in treating ischemic stroke.